<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer-Verlag</PublisherName>
    <PublisherLocation>New York</PublisherLocation>
  </PublisherInfo>
  <Journal>
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>12248</JournalID>
      <JournalElectronicISSN>1550-7416</JournalElectronicISSN>
      <JournalTitle>The AAPS Journal</JournalTitle>
      <JournalAbbreviatedTitle>AAPS J</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="F" Type="Primary">Pharmacy</JournalSubject>
        <JournalSubject Code="F00008" Priority="1" Type="Secondary">Pharmacy</JournalSubject>
        <JournalSubject Code="B21007" Priority="2" Type="Secondary">Pharmacology/Toxicology</JournalSubject>
        <JournalSubject Code="C12002" Priority="3" Type="Secondary">Biotechnology</JournalSubject>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume>
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>7</VolumeIDStart>
        <VolumeIDEnd>7</VolumeIDEnd>
        <VolumeIssueCount>4</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular">
        <IssueInfo TocLevels="0">
          <IssueIDStart>1</IssueIDStart>
          <IssueIDEnd>1</IssueIDEnd>
          <IssueArticleCount>25</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2005</Year>
              <Month>3</Month>
            </CoverDate>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
            <CopyrightYear>2005</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="Art15">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>71143</ArticleID>
            <ArticleDOI>10.1208/aapsj070115</ArticleDOI>
            <ArticleSequenceNumber>15</ArticleSequenceNumber>
            <ArticleTitle Language="En">Ajulemic acid (IP-751): Synthesis, proof of principle, toxicity studies, and clinical trials</ArticleTitle>
            <ArticleFirstPage>E143</ArticleFirstPage>
            <ArticleLastPage>E148</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2008</Year>
                <Month>1</Month>
                <Day>28</Day>
              </RegistrationDate>
              <Received>
                <Year>2004</Year>
                <Month>9</Month>
                <Day>27</Day>
              </Received>
              <Accepted>
                <Year>2004</Year>
                <Month>12</Month>
                <Day>12</Day>
              </Accepted>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
              <CopyrightYear>2005</CopyrightYear>
            </ArticleCopyright>
            <ArticleGrants Type="Regular">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="Restricted"/>
              <BodyHTMLGrant Grant="Restricted"/>
              <BibliographyGrant Grant="Restricted"/>
              <ESMGrant Grant="Restricted"/>
            </ArticleGrants>
            <ArticleContext>
              <JournalID>12248</JournalID>
              <VolumeIDStart>7</VolumeIDStart>
              <VolumeIDEnd>7</VolumeIDEnd>
              <IssueIDStart>1</IssueIDStart>
              <IssueIDEnd>1</IssueIDEnd>
            </ArticleContext>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Summer</GivenName>
                  <FamilyName>Burstein</FamilyName>
                </AuthorName>
                <Contact>
                  <Phone>(508) 856-2850</Phone>
                  <Fax>(508) 856-2003</Fax>
                  <Email>sumner.burstein@umassmed.edu</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>Department of Biochemistry and Molecular Pharmacology</OrgDivision>
                <OrgName>University of Massachusetts Medical School</OrgName>
                <OrgAddress>
                  <Street>364 Plantation Street</Street>
                  <Postcode>01605</Postcode>
                  <City>Worcester</City>
                  <State>MA</State>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En">
              <Heading>Abstract</Heading>
              <Para>Ajulemic acid (CT-3, IP-751,1’,1’-dimethylheptyl-Δ<Superscript>8</Superscript> acid) (AJA) has a cannabinoid-derived structure; however, there is no evidence that it produces psychotropic actions when given at therapeutic doses. In a variety of animal assays, AJA shows efficacy in models for pain and inflammation. Furthermore, in the rat adjuvant arthritis model, it displayed a remarkable action in preventing the destruction of inflamed joints. A phase-2 human trial with chronic, neuropathic pain patients suggested that AJA could become a useful drug for treating this condition. Its low toxicity, particularly its lack of ulcerogenicity, further suggests that it will have a highly favorable therapeutic index and may replace some of the current anti-inflammatory/analgesic medications. Studies to date indicate a unique mechanism of action for AJA that may explain its lack of adverse side effects.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Keywords</Heading>
              <Keyword>ajulemic acid</Keyword>
              <Keyword>analgesia</Keyword>
              <Keyword>anti-inflammatory</Keyword>
              <Keyword>cannabinoid</Keyword>
              <Keyword>IP-751</Keyword>
            </KeywordGroup>
            <ArticleNote Type="Misc">
              <SimplePara>Published: June 29, 2005</SimplePara>
            </ArticleNote>
          </ArticleHeader>
          <BodyRef FileRef="BodyRef/PDF/12248_2008_Article_71143.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Burstein</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ChapterTitle Language="En">Therapeutic Potential of Ajulemic Acid (CT-3)</ChapterTitle>
                  <BibEditorName>
                    <Initials>F</Initials>
                    <FamilyName>Grontenhermen</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>E</Initials>
                    <FamilyName>Russo</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Cannabis and Cannabinoids</BookTitle>
                  <PublisherName>Haworth Press Inc</PublisherName>
                  <PublisherLocation>Binghamton, NY</PublisherLocation>
                  <FirstPage>381</FirstPage>
                  <LastPage>388</LastPage>
                </BibChapter>
                <BibUnstructured>Burstein S. Therapeutic Potential of Ajulemic Acid (CT-3): In: Grontenhermen F, Russo E, eds.<Emphasis Type="Italic">Cannabis and Cannabinoids</Emphasis>. Binghamton, NY: Haworth Press Inc; 2002;381–388.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SH</Initials>
                    <FamilyName>Burstein</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Ajulemic acid (CT3): a potent analog of the acid metabolites of THC</ArticleTitle>
                  <JournalTitle>Curr Pharm Des.</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <FirstPage>1339</FirstPage>
                  <LastPage>1345</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10903396</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.2174/1381612003399473</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXmtFChsb4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Burstein SH. Ajulemic acid (CT3): a potent analog of the acid metabolites of THC.<Emphasis Type="Italic">Curr Pharm Des.</Emphasis> 2000;6:1339–1345.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SH</Initials>
                    <FamilyName>Burstein</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">The cannabinoid acids: nonpsychoactive derivatives with therapeutic potential</ArticleTitle>
                  <JournalTitle>Pharmacol Ther.</JournalTitle>
                  <VolumeID>82</VolumeID>
                  <FirstPage>87</FirstPage>
                  <LastPage>96</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10341359</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0163-7258(98)00069-2</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXitF2jtL4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Burstein SH. The cannabinoid acids: nonpsychoactive derivatives with therapeutic potential.<Emphasis Type="Italic">Pharmacol Ther.</Emphasis> 1999;82:87–96.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SH</Initials>
                    <FamilyName>Burstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Karst</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>U</Initials>
                    <FamilyName>Schneider</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RB</Initials>
                    <FamilyName>Zurier</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Ajulemic acid: a novel cannabinoid produces analgesia without a “high”</ArticleTitle>
                  <JournalTitle>Life Sci.</JournalTitle>
                  <VolumeID>75</VolumeID>
                  <FirstPage>1513</FirstPage>
                  <LastPage>1522</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15240185</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.lfs.2004.04.010</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXlsFylsbc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Burstein SH, Karst M, Schneider U, Zurier RB. Ajulemic acid: a novel cannabinoid produces analgesia without a “high”.<Emphasis Type="Italic">Life Sci.</Emphasis> 2004;75:1513–1522.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Burstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Hunter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Latham</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Renzulli</FamilyName>
                  </BibAuthorName>
                  <Year>1987</Year>
                  <ArticleTitle Language="En">A major metabolite of delta 1-tetrahydrocannabinol reduces its cataleptic effect in mice</ArticleTitle>
                  <JournalTitle>Experientia.</JournalTitle>
                  <VolumeID>43</VolumeID>
                  <FirstPage>402</FirstPage>
                  <LastPage>403</LastPage>
                  <Occurrence Type="PID">
                    <Handle>3032669</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/BF01940427</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL2sXktFOku7c%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Burstein S, Hunter SA, Latham V, Renzulli L. A major metabolite of delta 1-tetrahydrocannabinol reduces its cataleptic effect in mice.<Emphasis Type="Italic">Experientia.</Emphasis> 1987;43:402–403.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Burstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TS</Initials>
                    <FamilyName>Shoupe</FamilyName>
                  </BibAuthorName>
                  <Year>1981</Year>
                  <ArticleTitle Language="En">Metabolic pathways for the transformation of delta 1-tetrahydrocannabinol in mouse hepatic microsomes</ArticleTitle>
                  <JournalTitle>Drug Metab Dispos.</JournalTitle>
                  <VolumeID>9</VolumeID>
                  <FirstPage>94</FirstPage>
                  <LastPage>96</LastPage>
                  <Occurrence Type="PID">
                    <Handle>6113124</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL3MXhvVGgt78%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Burstein S, Shoupe TS. Metabolic pathways for the transformation of delta 1-tetrahydrocannabinol in mouse hepatic microsomes.<Emphasis Type="Italic">Drug Metab Dispos.</Emphasis> 1981;9:94–96.</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Burstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Rosenfeld</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Wittstruck</FamilyName>
                  </BibAuthorName>
                  <Year>1972</Year>
                  <ArticleTitle Language="En">Isolation and characterization of two major urinary metabolites of 1-tetrahydrocannabinol</ArticleTitle>
                  <JournalTitle>Science.</JournalTitle>
                  <VolumeID>176</VolumeID>
                  <FirstPage>422</FirstPage>
                  <LastPage>423</LastPage>
                  <Occurrence Type="PID">
                    <Handle>5026162</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.176.4033.422</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaE38XksVertLg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Burstein S, Rosenfeld J, Wittstruck T. Isolation and characterization of two major urinary metabolites of 1-tetrahydrocannabinol.<Emphasis Type="Italic">Science.</Emphasis> 1972;176:422–423.</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SH</Initials>
                    <FamilyName>Burstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Kupfer</FamilyName>
                  </BibAuthorName>
                  <Year>1971</Year>
                  <ArticleTitle Language="En">Hydroxylation of trans-1-tetrahydrocannabinol by a hepatic microsomal monooxygenase</ArticleTitle>
                  <JournalTitle>Chem Biol Interact.</JournalTitle>
                  <VolumeID>3</VolumeID>
                  <FirstPage>316</FirstPage>
                  <LastPage>316</LastPage>
                  <Occurrence Type="PID">
                    <Handle>5133015</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0009-2797(71)90078-0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaE3MXltVGntLw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Burstein SH, Kupfer D. Hydroxylation of trans-1-tetrahydrocannabinol by a hepatic microsomal monooxygenase.<Emphasis Type="Italic">Chem Biol Interact.</Emphasis> 1971;3:316.</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SH</Initials>
                    <FamilyName>Burstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Menezes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Williamson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Mechoulam</FamilyName>
                  </BibAuthorName>
                  <Year>1970</Year>
                  <ArticleTitle Language="En">Metabolism of delta 1(6)-tetrahydro-cannabinol, an active marihuana constituent</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>225</VolumeID>
                  <FirstPage>87</FirstPage>
                  <LastPage>88</LastPage>
                  <Occurrence Type="PID">
                    <Handle>5410211</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/225087a0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaE3cXpvVOmug%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Burstein SH, Menezes F, Williamson E, Mechoulam R. Metabolism of delta 1(6)-tetrahydro-cannabinol, an active marihuana constituent.<Emphasis Type="Italic">Nature</Emphasis>, 1970;225:87–88.</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Perez-Reyes</FamilyName>
                  </BibAuthorName>
                  <Year>1985</Year>
                  <ChapterTitle Language="En">Pharmacodynamics of certain drugs of abuse</ChapterTitle>
                  <BibEditorName>
                    <Initials>G</Initials>
                    <FamilyName>Barnett</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>CN</Initials>
                    <FamilyName>Chang</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Pharmacokinetics and Pharmacodynamics of Psychoactive Drugs</BookTitle>
                  <PublisherName>Biomedical Publishers</PublisherName>
                  <PublisherLocation>Foster City, CA</PublisherLocation>
                  <FirstPage>287</FirstPage>
                  <LastPage>310</LastPage>
                </BibChapter>
                <BibUnstructured>Perez-Reyes M. Pharmacodynamics of certain drugs of abuse. In: Barnett G, Chang CN, eds.<Emphasis Type="Italic">Pharmacokinetics and Pharmacodynamics of Psychoactive Drugs</Emphasis>. Foster City, CA: Biomedical Publishers; 1985;287–310.</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Burstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Hunter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Latham</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Renzulli</FamilyName>
                  </BibAuthorName>
                  <Year>1986</Year>
                  <ArticleTitle Language="En">Prostaglandins and cannabis-XVI. Antagonism of delta 1-tetrahydrocannabinol action by its metabolites</ArticleTitle>
                  <JournalTitle>Biochem Pharmacol.</JournalTitle>
                  <VolumeID>35</VolumeID>
                  <FirstPage>2553</FirstPage>
                  <LastPage>2558</LastPage>
                  <Occurrence Type="PID">
                    <Handle>3017356</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0006-2952(86)90053-5</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL28Xlt1Oht7w%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Burstein S, Hunter SA, Latham V, Renzulli L. Prostaglandins and cannabis-XVI. Antagonism of delta 1-tetrahydrocannabinol action by its metabolites.<Emphasis Type="Italic">Biochem Pharmacol.</Emphasis> 1986;35:2553–2558.</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SH</Initials>
                    <FamilyName>Burstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Hull</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Hunter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Latham</FamilyName>
                  </BibAuthorName>
                  <Year>1988</Year>
                  <ArticleTitle Language="En">Cannabinoids and pain responses: a possible role for prostaglandins</ArticleTitle>
                  <JournalTitle>FASEB J.</JournalTitle>
                  <VolumeID>2</VolumeID>
                  <FirstPage>3022</FirstPage>
                  <LastPage>3026</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2846397</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1MXhvVCjtQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Burstein SH, Hull K, Hunter SA, Latham V. Cannabinoids and pain responses: a possible role for prostaglandins.<Emphasis Type="Italic">FASEB J.</Emphasis> 1988;2:3022–3026.</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SH</Initials>
                    <FamilyName>Burstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CA</Initials>
                    <FamilyName>Audette</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Doyle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Hull</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Hunter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Latham</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">Antagonism to the actions of platelet activating factor by a non-psychoactive cannabinoid</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>251</VolumeID>
                  <FirstPage>531</FirstPage>
                  <LastPage>535</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2553925</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3cXmvFGktg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Burstein SH, Audette CA, Doyle SA, Hull K, Hunter SA, Latham V. Antagonism to the actions of platelet activating factor by a non-psychoactive cannabinoid.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1989;251:531–535.</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Doyle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SH</Initials>
                    <FamilyName>Burstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WL</Initials>
                    <FamilyName>Dewey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SP</Initials>
                    <FamilyName>Welch</FamilyName>
                  </BibAuthorName>
                  <Year>1990</Year>
                  <ArticleTitle Language="En">Further studies on the antinociceptive effects of delta 6-THC-7-oic acid</ArticleTitle>
                  <JournalTitle>Agents Actions.</JournalTitle>
                  <VolumeID>31</VolumeID>
                  <FirstPage>157</FirstPage>
                  <LastPage>163</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2178317</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/BF02003237</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3cXlsVGhtb8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Doyle SA, Burstein SH, Dewey WL, Welch SP. Further studies on the antinociceptive effects of delta 6-THC-7-oic acid.<Emphasis Type="Italic">Agents Actions.</Emphasis> 1990;31:157–163.</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SH</Initials>
                    <FamilyName>Burstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CA</Initials>
                    <FamilyName>Audette</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Breuer</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activities</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>35</VolumeID>
                  <FirstPage>3135</FirstPage>
                  <LastPage>3141</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1507202</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm00095a007</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK38XltlWgurc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Burstein SH, Audette CA, Breuer A, et al. Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activities.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1992;35: 3135–3141.</BibUnstructured>
              </Citation>
              <Citation ID="CR16">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Karst</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Salim</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Burstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Conrad</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Hoy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>U</Initials>
                    <FamilyName>Schneider</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial</ArticleTitle>
                  <JournalTitle>JAMA.</JournalTitle>
                  <VolumeID>290</VolumeID>
                  <FirstPage>1757</FirstPage>
                  <LastPage>1762</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14519710</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1001/jama.290.13.1757</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXnvVyiu7g%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Karst M, Salim K, Burstein S, Conrad I, Hoy L, Schneider U. Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial.<Emphasis Type="Italic">JAMA.</Emphasis> 2003;290: 1757–1762.</BibUnstructured>
              </Citation>
              <Citation ID="CR17">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MH</Initials>
                    <FamilyName>Rhee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Z</Initials>
                    <FamilyName>Vogel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Barg</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>40</VolumeID>
                  <FirstPage>3228</FirstPage>
                  <LastPage>3233</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9379442</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm970126f</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXmtVehsLg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rhee MH, Vogel Z, Barg J, et al. Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1997;40:3228–3233.</BibUnstructured>
              </Citation>
              <Citation ID="CR18">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DR</Initials>
                    <FamilyName>Compton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KC</Initials>
                    <FamilyName>Rice</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BR</Initials>
                    <FamilyName>Costa</FamilyName>
                    <Particle>De</Particle>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>265</VolumeID>
                  <FirstPage>218</FirstPage>
                  <LastPage>226</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8474008</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXks1ansLs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Compton DR, Rice KC, De Costa BR, et al. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1993;265:218–226.</BibUnstructured>
              </Citation>
              <Citation ID="CR19">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LD</Initials>
                    <FamilyName>Recht</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Salmonsen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Rosetti</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid</ArticleTitle>
                  <JournalTitle>Biochem Pharmacol.</JournalTitle>
                  <VolumeID>62</VolumeID>
                  <FirstPage>755</FirstPage>
                  <LastPage>763</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11551521</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0006-2952(01)00700-6</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXms1Oks70%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Recht LD, Salmonsen R, Rosetti R, et al. Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid.<Emphasis Type="Italic">Biochem Pharmacol.</Emphasis> 2001;62:755–763.</BibUnstructured>
              </Citation>
              <Citation ID="CR20">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Hunter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SH</Initials>
                    <FamilyName>Burstein</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Receptor mediation in cannabinoid stimulated arachidonic acid mobilization and anandamide synthesis</ArticleTitle>
                  <JournalTitle>Life Sci.</JournalTitle>
                  <VolumeID>60</VolumeID>
                  <FirstPage>1563</FirstPage>
                  <LastPage>1573</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9126878</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0024-3205(97)00122-7</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXitl2ms7o%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hunter SA, Burstein SH. Receptor mediation in cannabinoid stimulated arachidonic acid mobilization and anandamide synthesis.<Emphasis Type="Italic">Life Sci.</Emphasis> 1997;60:1563–1573.</BibUnstructured>
              </Citation>
              <Citation ID="CR21">
                <CitationNumber>21.</CitationNumber>
                <BibUnstructured>Stebulis JA, Burstein SH, Torres R, et al. Ajulemic Acid, an antiinflammatory nonpsychoactive cannabinoid acid, modulates activation of human synovial cells. Paper presented at: 2004 Symposium on the Cannabinoids. June 20, 2004; Paestum, Italy.</BibUnstructured>
              </Citation>
              <Citation ID="CR22">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RB</Initials>
                    <FamilyName>Zurier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RG</Initials>
                    <FamilyName>Rossetti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Lane</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Goldberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Hunter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SH</Initials>
                    <FamilyName>Burstein</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Dimethylheptyl-THC-11-oic acid: a nonpsychoactive antiinflammatory agent with a cannabinoid template structure</ArticleTitle>
                  <JournalTitle>Arthritis Rheum.</JournalTitle>
                  <VolumeID>41</VolumeID>
                  <FirstPage>163</FirstPage>
                  <LastPage>170</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9433882</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/1529-0131(199801)41:1&lt;163::AID-ART20&gt;3.0.CO;2-9</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXmslyrsg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zurier RB, Rossetti RG, Lane JH, Goldberg JM, Hunter SA, Burstein SH. Dimethylheptyl-THC-11-oic acid: a nonpsychoactive antiinflammatory agent with a cannabinoid template structure.<Emphasis Type="Italic">Arthritis Rheum.</Emphasis> 1998;41:163–170.</BibUnstructured>
              </Citation>
              <Citation ID="CR23">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>EZ</Initials>
                    <FamilyName>Dajani</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KR</Initials>
                    <FamilyName>Larsen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Taylor</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">1′,1′-Dimethylheptyl-delta-8-tetrahydrocannabinol-11-oic acid: a novel, orally effective cannabinoid with analgesic and anti-inflammatory properties</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>291</VolumeID>
                  <FirstPage>31</FirstPage>
                  <LastPage>38</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10490883</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXmtlalu7c%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dajani EZ, Larsen KR, Taylor J, et al. 1′,1′-Dimethylheptyl-delta-8-tetrahydrocannabinol-11-oic acid: a novel, orally effective cannabinoid with analgesic and anti-inflammatory properties.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1999;291:31–38.</BibUnstructured>
              </Citation>
              <Citation ID="CR24">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SH</Initials>
                    <FamilyName>Burstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Friderichs</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Kogel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Schneider</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Selve</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Analgesic effects of 1′,1′ dimethylheptyl-delta8-THC-11-oic acid (CT3) in mice</ArticleTitle>
                  <JournalTitle>Life Sci.</JournalTitle>
                  <VolumeID>63</VolumeID>
                  <FirstPage>161</FirstPage>
                  <LastPage>168</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9698045</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0024-3205(98)00256-2</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXktV2gtrY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Burstein SH, Friderichs E, Kogel B, Schneider J, Selve N. Analgesic effects of 1′,1′ dimethylheptyl-delta8-THC-11-oic acid (CT3) in mice.<Emphasis Type="Italic">Life Sci.</Emphasis> 1998;63:161–168.</BibUnstructured>
              </Citation>
              <Citation ID="CR25">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Bidinger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Torres</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RG</Initials>
                    <FamilyName>Rossetti</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Ajulemic acid, a nonpsychoactive cannabinoid acid, induces apoptosis in human T lymphocytes</ArticleTitle>
                  <JournalTitle>Clin Immunol.</JournalTitle>
                  <VolumeID>108</VolumeID>
                  <FirstPage>95</FirstPage>
                  <LastPage>102</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12921755</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S1521-6616(03)00064-0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXmt1Wqtrs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bidinger B, Torres R, Rossetti RG, et al. Ajulemic acid, a nonpsychoactive cannabinoid acid, induces apoptosis in human T lymphocytes.<Emphasis Type="Italic">Clin Immunol.</Emphasis> 2003;108:95–102.</BibUnstructured>
              </Citation>
              <Citation ID="CR26">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Liu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Li</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SH</Initials>
                    <FamilyName>Burstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RB</Initials>
                    <FamilyName>Zurier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Chen</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid</ArticleTitle>
                  <JournalTitle>Mol Pharmacol.</JournalTitle>
                  <VolumeID>63</VolumeID>
                  <FirstPage>983</FirstPage>
                  <LastPage>992</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12695526</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/mol.63.5.983</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXjt12lurg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Liu J, Li, H, Burstein SH, Zurier RB, Chen JD. Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid.<Emphasis Type="Italic">Mol Pharmacol.</Emphasis> 2003;63:983–992.</BibUnstructured>
              </Citation>
              <Citation ID="CR27">
                <CitationNumber>27.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RB</Initials>
                    <FamilyName>Zurier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RG</Initials>
                    <FamilyName>Rossetti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SH</Initials>
                    <FamilyName>Burstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Bidinger</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Suppression of human monocyte interleukin-1 beta production by ajulemic acid, a nonpsychoactive cannabinoid</ArticleTitle>
                  <JournalTitle>Biochem Pharmacol.</JournalTitle>
                  <VolumeID>65</VolumeID>
                  <FirstPage>649</FirstPage>
                  <LastPage>655</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12566094</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0006-2952(02)01604-0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXptFCqug%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zurier RB, Rossetti RG, Burstein SH, Bidinger B. Suppression of human monocyte interleukin-1 beta production by ajulemic acid, a nonpsychoactive cannabinoid.<Emphasis Type="Italic">Biochem Pharmacol.</Emphasis> 2003;65:649–655.</BibUnstructured>
              </Citation>
              <Citation ID="CR28">
                <CitationNumber>28.</CitationNumber>
                <BibUnstructured>Walker JM, Owen K, Petros P, Huang SM. Antiallodynic and analgesic actions of ajulemic acid reversed by a cannabinoid antagonist. Paper presented at: Society of Neuroscientists; November 9, 2000; New Orleans, LA.</BibUnstructured>
              </Citation>
              <Citation ID="CR29">
                <CitationNumber>29.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PF</Initials>
                    <FamilyName>Sumariwalla</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Gallily</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Tchilibon</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Fride</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Mechoulam</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Feldmann</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis</ArticleTitle>
                  <JournalTitle>Arthritis Rheum.</JournalTitle>
                  <VolumeID>50</VolumeID>
                  <FirstPage>985</FirstPage>
                  <LastPage>998</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15022343</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/art.20050</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXjtVCrsLs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sumariwalla PF, Gallily R, Tchilibon S, Fride E, Mechoulam R, Feldmann M. A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis.<Emphasis Type="Italic">Arthritis Rheum.</Emphasis> 2004;50:985–998.</BibUnstructured>
              </Citation>
              <Citation ID="CR30">
                <CitationNumber>30.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SH</Initials>
                    <FamilyName>Burstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RB</Initials>
                    <FamilyName>Zurier</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Pain reduction and lack of psychotropic effects with ajulemic acid: comment on the article by Sumariwalla et al.</ArticleTitle>
                  <JournalTitle>Arthritis Rheum.</JournalTitle>
                  <VolumeID>50</VolumeID>
                  <FirstPage>4078</FirstPage>
                  <LastPage>4080</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15593192</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/art.20805</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Burstein SH, Zurier RB. Pain reduction and lack of psychotropic effects with ajulemic acid: comment on the article by Sumariwalla et al.<Emphasis Type="Italic">Arthritis Rheum.</Emphasis> 2004;50:4078–4080.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
